We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$576B
AUM Growth
+$48.6B
Cap. Flow
-$29.1B
Cap. Flow %
-5.06%
Top 10 Hldgs %
27.06%
Holding
15,819
New
1,459
Increased
5,619
Reduced
5,141
Closed
3,524

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$820M
2
MSFT icon
Microsoft
MSFT
+$811M
3
MCD icon
McDonald's
MCD
+$804M
4
KO icon
Coca-Cola
KO
+$655M
5
AMZN icon
Amazon
AMZN
+$646M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$1.64B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$1.1B
3
MSTR icon
Strategy Inc
MSTR
+$564M
4
KR icon
Kroger
KR
+$558M
5
DHR icon
Danaher
DHR
+$494M

Sector Composition

Rank Sector Weight
1 Technology 3.33%
2 Healthcare 3.23%
3 Consumer Discretionary 2.55%
4 Financials 2.55%
5 Industrials 1.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RANI icon
12176
CALL
Rani Therapeutics
RANI
$89.5M
$7.2K ﹤0.01%
14,000
-7,300
-34% -$5.96K
ARBK
12177
CALL
Argo Blockchain
ARBK
$42.1M
$7.03K ﹤0.01%
174
+161
+1,238% +$13.1K
APLMW icon
12178
Apollomics Inc Warrant
APLMW
$1.61M
$7.02K ﹤0.01%
158,131
-81,134
-34% -$1.35K
EONR.WS
12179
EON Resources Warrants
EONR.WS
$1.43M
$6.88K ﹤0.01%
134,622
+55,218
+70% +$2.54K
RVPH
12180
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$6.82K ﹤0.01%
895
-290
-24% -$4.52K
BNKK
12181
CALL
Bonk Inc
BNKK
$8.64M
$6.14K ﹤0.01%
531
+197
+59% +$2.66K
LOBO
12182
Lobo Technologies Ltd
LOBO
$9.16M
$5.8K ﹤0.01%
+11,769
New +$8.64K
OPI
12183
PUT
DELISTED
Office Properties Income Trust
OPI
$5.78K ﹤0.01%
23,400
+6,200
+36% +$1.74K
SBFMW
12184
Sunshine Biopharma Inc Warrant
SBFMW
$131K
$5.31K ﹤0.01%
20,415
-10,130
-33% -$2.61K
RYDE icon
12185
Ryde Group
RYDE
$157M
$5.23K ﹤0.01%
17,437
-218,974
-93% -$51.7K
ECDAW
12186
DELISTED
ECD Automotive Design Warrant
ECDAW
$5.18K ﹤0.01%
216,906
-6,095
-3% -$105
OVID icon
12187
CALL
Ovid Therapeutics
OVID
$553M
$5.15K ﹤0.01%
15,600
+13,900
+818% +$4.19K
HBIO icon
12188
PUT
Harvard Bioscience
HBIO
$30.3M
$5.1K ﹤0.01%
1,150
+950
+475% +$3.97K
PASG icon
12189
CALL
Passage Bio
PASG
$14.8M
$5K ﹤0.01%
+625
New +$4.57K
GRDX
12190
GridAI Technologies Corp
GRDX
$29.5M
$4.97K ﹤0.01%
+4,138
New +$5.3K
UBX
12191
PUT
DELISTED
Unity Biotechnology
UBX
$4.86K ﹤0.01%
12,800
+2,500
+24% +$2.14K
ALXO icon
12192
PUT
ALX Oncology
ALXO
$271M
$4.86K ﹤0.01%
11,700
-25,200
-68% -$12.7K
PRPH
12193
CALL
DELISTED
ProPhase Labs
PRPH
$4.81K ﹤0.01%
+1,230
New +$4.11K
BNZIW
12194
DELISTED
Banzai International Warrant
BNZIW
$4.69K ﹤0.01%
211,189
-24,352
-10% -$580
WATT icon
12195
Energous
WATT
$86M
$4.56K ﹤0.01%
+557
New +$4.62K
FERAR
12196
Fifth Era Acquisition Corp I Rights
FERAR
$4.5K ﹤0.01%
+16,000
New +$3.56K
HCWC
12197
Healthy Choice Wellness
HCWC
$7.05M
$4.47K ﹤0.01%
+11,075
New +$4.56K
CMBM
12198
CALL
DELISTED
Cambium Networks
CMBM
$4.37K ﹤0.01%
10,800
-6,500
-38% -$2.53K
LNZA icon
12199
CALL
LanzaTech
LNZA
$83M
$4.26K ﹤0.01%
157
-262
-63% -$6.42K
BIAFW icon
12200
bioAffinity Technologies
BIAFW
$4.21K ﹤0.01%
32,355
-3,633
-10% -$636

Similar funds

Citadel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Citadel Advisors held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Citadel Advisors withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Walmart Inc worth $401M.

  • Citadel Advisors's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
  • Citadel Advisors added most to NVIDIA in Q2 2025, an estimated $820M increase.
  • Citadel Advisors's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
  • Citadel Advisors fully exited Kroger in Q2 2025, selling an estimated $558M.
  • Citadel Advisors's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
  • Citadel Advisors opened 1,459 new positions and closed 3,524 in Q2 2025.
  • Citadel Advisors's portfolio value rose 9.2% quarter-over-quarter to $576B.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.